DE LUCA, ANASTASIA
DE LUCA, ANASTASIA
Dipartimento di Biologia
A new nitrobenzoxadiazole-based GSTP1-1 inhibitor with a previously unheard of mechanism of action and high stability
2017-01-01 Fulci, C; Rotili, D; DE LUCA, A; Stella, L; MOROZZO DELLA ROCCA, B; Forgione, M; Di Paolo, V; Mai, A; Falconi, M; Quintieri, L; Caccuri, Am
A new target for gold(I) compounds: glutathione-S-transferase inhibition by auranofin
2013-02-01 De Luca, A; Hartinger, C; Dyson, P; LO BELLO, M; Casini, A
A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib
2015-01-01 Graziani, G; Artuso, S; De Luca, A; Muzi, A; Rotili, D; Scimeca, M; Atzori, M; Ceci, C; Mai, A; Leonetti, C; Levati, L; Bonanno, E; Tentori, L; Caccuri, Am
A novel orally active water-soluble inhibitor of human glutathione transferase exerts a potent and selective antitumor activity against human melanoma xenografts
2015-01-01 De Luca, A; Rotili, D; Carpanese, D; Lenoci, A; Calderan, L; Scimeca, M; Mai, A; Bonanno, E; Rosato, A; Geroni, C; Quintieri, L; Caccuri, Am; DE LUCA, A
A novel water-soluble nitrobenzoxadiazole is highly effective against vemurafenib-resistant human melanoma cells
2015-01-01 DE LUCA, A; Graziani, G; Rotili, D; Muzi, A; Mai, A; Leonetti, C; Artuso, S; Bonanno, E; Tentori, L; Caccuri, Am
A spotlight on the role of copper in the epithelial to mesenchymal transition
2024-08-01 Focaccio, A; Rossi, L; De Luca, A
A structure-based mechanism of cisplatin resistance mediated by glutathione transferase P1-1
2019-06-20 De Luca, A; Parker, Lj; Ang, Wh; Rodolfo, C; Gabbarini, V; Hancock, Nc; Palone, F; Mazzetti, Ap; Menin, L; Morton, Cj; Parker, Mw; Lo Bello, M; Dyson, Pj
Age-Dependent Dysregulation of APP in Neuronal and Skin Cells from Fragile X Individuals
2023-02-27 Cencelli, G; Pacini, L; De Luca, A; Messia, I; Gentile, A; Kang, Y; Nobile, V; Tabolacci, E; Jin, P; Farace, Mg; Bagni, C
AKT-driven epithelial-mesenchymal transition in triple negative breast cancer cells is affected by copper bioavailability via a Her2/LOXL2-independent pathway
2022-09-19 Vitaliti, A; Roccatani, I; Iorio, E; Perta, N; Gismondi, A; Chirico, M; Elena Pisanu, M; DI MARINO, D; Canini, A; DE LUCA, A; Rossi, L
AKT-driven epithelial-mesenchymal transition is affected by copper bioavailability in HER2 negative breast cancer cells via a LOXL2-independent mechanism
2023-01-01 Vitaliti, A; Roccatani, I; Iorio, E; Perta, N; Gismondi, A; Chirico, M; Pisanu, Me; Di Marino, D; Canini, A; De Luca, A; Rossi, L
Allergic contact dermatitis: novel mechanisms and therapeutic perspectives
2010-01-01 Cavani, A; De Luca, A
Antioxidant Properties of Lippia alba Essential Oil: A Potential Treatment for Oxidative Stress-Related Conditions in Plants and Cancer Cells
2024-07-29 Borromeo, I; DE LUCA, A; Domenici, F; Giordani, C; Rossi, L; Forni, C
c-Jun N-terminal kinase activation by nitrobenzoxadiazoles leads to late-stage autophagy inhibition
2016-02-04 Palumbo, C; De Luca, A; Rosato, N; Forgione, M; Rotili, D; Caccuri, Am
Characterization of water-soluble esters of nitrobenzoxadiazole-based GSTP1-1 inhibitors for cancer treatment
2020-01-01 Di Paolo, V; Fulci, C; Rotili, D; De Luca, A; Tomassi, S; Serra, M; Scimeca, M; Geroni, C; Quintieri, L; Caccuri, Am
Circulating Tumor Cells: Origin, Role, Current Applications, and Future Perspectives for Personalized Medicine
2024-01-01 Cristina Rapanotti, M; Cenci, T; Scioli, Mg; Cugini, E; Anzillotti, S; Savino, L; Coletta, D; DI RAIMONDO, C; Campione, E; Roselli, M; Bernardini, S; Bianchi, L; DE LUCA, A; Ferlosio, A; Orlandi, A
Copper homeostasis as target of both consolidated and innovative strategies of anti-tumor therapy.
2019-09-01 De Luca, A; Barile, A; Arciello, M; Rossi, L
Copper in tumors and the use of copper-based compounds in cancer treatment
2022-01-01 da Silva, Da; De Luca, A; Squitti, R; Rongioletti, M; Rossi, L; Machado, Cml; Cerchiaro, G
Copper-Dependent Kinases and Their Role in Cancer Inception, Progression and Metastasis
2022-01-01 Vitaliti, A; De Luca, A; Rossi, L
Editorial: Metals in cancer: from intracellular signaling to therapy
2024-01-01 Aquilano, K; Filomeni, G; Faraonio, R; De Luca, A
Effective squaric acid dibutylester immunotherapy is associated with a reduction of skin infiltrating T-helper (Th)1 and Th17 cells in alopecia areata patients
2015-01-01 Avitabile, S; Sordi, D; Garcovich, S; Colonna, L; De Luca, A; Nasorri, F; Mazzanti, C; Cavani, A
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2017 | A new nitrobenzoxadiazole-based GSTP1-1 inhibitor with a previously unheard of mechanism of action and high stability | Fulci, C; Rotili, D; DE LUCA, A; Stella, L; MOROZZO DELLA ROCCA, B; Forgione, M; Di Paolo, V; Mai, A; Falconi, M; Quintieri, L; Caccuri, Am | Articolo su rivista | |
| 1-feb-2013 | A new target for gold(I) compounds: glutathione-S-transferase inhibition by auranofin | De Luca, A; Hartinger, C; Dyson, P; LO BELLO, M; Casini, A | Articolo su rivista | |
| 1-gen-2015 | A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib | Graziani, G; Artuso, S; De Luca, A; Muzi, A; Rotili, D; Scimeca, M; Atzori, M; Ceci, C; Mai, A; Leonetti, C; Levati, L; Bonanno, E; Tentori, L; Caccuri, Am | Articolo su rivista | |
| 1-gen-2015 | A novel orally active water-soluble inhibitor of human glutathione transferase exerts a potent and selective antitumor activity against human melanoma xenografts | De Luca, A; Rotili, D; Carpanese, D; Lenoci, A; Calderan, L; Scimeca, M; Mai, A; Bonanno, E; Rosato, A; Geroni, C; Quintieri, L; Caccuri, Am; DE LUCA, A | Articolo su rivista | |
| 1-gen-2015 | A novel water-soluble nitrobenzoxadiazole is highly effective against vemurafenib-resistant human melanoma cells | DE LUCA, A; Graziani, G; Rotili, D; Muzi, A; Mai, A; Leonetti, C; Artuso, S; Bonanno, E; Tentori, L; Caccuri, Am | Intervento a convegno | |
| 1-ago-2024 | A spotlight on the role of copper in the epithelial to mesenchymal transition | Focaccio, A; Rossi, L; De Luca, A | Articolo su rivista | |
| 20-giu-2019 | A structure-based mechanism of cisplatin resistance mediated by glutathione transferase P1-1 | De Luca, A; Parker, Lj; Ang, Wh; Rodolfo, C; Gabbarini, V; Hancock, Nc; Palone, F; Mazzetti, Ap; Menin, L; Morton, Cj; Parker, Mw; Lo Bello, M; Dyson, Pj | Articolo su rivista | |
| 27-feb-2023 | Age-Dependent Dysregulation of APP in Neuronal and Skin Cells from Fragile X Individuals | Cencelli, G; Pacini, L; De Luca, A; Messia, I; Gentile, A; Kang, Y; Nobile, V; Tabolacci, E; Jin, P; Farace, Mg; Bagni, C | Articolo su rivista | |
| 19-set-2022 | AKT-driven epithelial-mesenchymal transition in triple negative breast cancer cells is affected by copper bioavailability via a Her2/LOXL2-independent pathway | Vitaliti, A; Roccatani, I; Iorio, E; Perta, N; Gismondi, A; Chirico, M; Elena Pisanu, M; DI MARINO, D; Canini, A; DE LUCA, A; Rossi, L | Intervento a convegno | |
| 1-gen-2023 | AKT-driven epithelial-mesenchymal transition is affected by copper bioavailability in HER2 negative breast cancer cells via a LOXL2-independent mechanism | Vitaliti, A; Roccatani, I; Iorio, E; Perta, N; Gismondi, A; Chirico, M; Pisanu, Me; Di Marino, D; Canini, A; De Luca, A; Rossi, L | Articolo su rivista | |
| 1-gen-2010 | Allergic contact dermatitis: novel mechanisms and therapeutic perspectives | Cavani, A; De Luca, A | Articolo su rivista | |
| 29-lug-2024 | Antioxidant Properties of Lippia alba Essential Oil: A Potential Treatment for Oxidative Stress-Related Conditions in Plants and Cancer Cells | Borromeo, I; DE LUCA, A; Domenici, F; Giordani, C; Rossi, L; Forni, C | Articolo su rivista | |
| 4-feb-2016 | c-Jun N-terminal kinase activation by nitrobenzoxadiazoles leads to late-stage autophagy inhibition | Palumbo, C; De Luca, A; Rosato, N; Forgione, M; Rotili, D; Caccuri, Am | Articolo su rivista | |
| 1-gen-2020 | Characterization of water-soluble esters of nitrobenzoxadiazole-based GSTP1-1 inhibitors for cancer treatment | Di Paolo, V; Fulci, C; Rotili, D; De Luca, A; Tomassi, S; Serra, M; Scimeca, M; Geroni, C; Quintieri, L; Caccuri, Am | Articolo su rivista | |
| 1-gen-2024 | Circulating Tumor Cells: Origin, Role, Current Applications, and Future Perspectives for Personalized Medicine | Cristina Rapanotti, M; Cenci, T; Scioli, Mg; Cugini, E; Anzillotti, S; Savino, L; Coletta, D; DI RAIMONDO, C; Campione, E; Roselli, M; Bernardini, S; Bianchi, L; DE LUCA, A; Ferlosio, A; Orlandi, A | Articolo su rivista | |
| 1-set-2019 | Copper homeostasis as target of both consolidated and innovative strategies of anti-tumor therapy. | De Luca, A; Barile, A; Arciello, M; Rossi, L | Articolo su rivista | |
| 1-gen-2022 | Copper in tumors and the use of copper-based compounds in cancer treatment | da Silva, Da; De Luca, A; Squitti, R; Rongioletti, M; Rossi, L; Machado, Cml; Cerchiaro, G | Articolo su rivista | |
| 1-gen-2022 | Copper-Dependent Kinases and Their Role in Cancer Inception, Progression and Metastasis | Vitaliti, A; De Luca, A; Rossi, L | Articolo su rivista | |
| 1-gen-2024 | Editorial: Metals in cancer: from intracellular signaling to therapy | Aquilano, K; Filomeni, G; Faraonio, R; De Luca, A | Articolo su rivista | |
| 1-gen-2015 | Effective squaric acid dibutylester immunotherapy is associated with a reduction of skin infiltrating T-helper (Th)1 and Th17 cells in alopecia areata patients | Avitabile, S; Sordi, D; Garcovich, S; Colonna, L; De Luca, A; Nasorri, F; Mazzanti, C; Cavani, A | Articolo su rivista |